STATE STREET CORP - GALENA BIOPHARMA INC ownership

GALENA BIOPHARMA INC's ticker is GALE and the CUSIP is 363256504. A total of 61 filers reported holding GALENA BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q4 2017$30,000
-25.0%
114,356
-0.1%
0.00%
Q3 2017$40,000
-39.4%
114,4310.0%0.00%
Q2 2017$66,000
-56.9%
114,431
-56.0%
0.00%
Q1 2017$153,000
-44.2%
259,925
+82.1%
0.00%
Q4 2016$274,000142,7660.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q1 2017
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 2,644,522$1,536,0000.10%
ELEMENT CAPITAL MANAGEMENT LLC 160,238$93,0000.02%
DAFNA Capital Management LLC 46,145$27,0000.02%
Crescent Grove Advisors, LLC 100,000$58,0000.02%
EQUITEC SPECIALISTS, LLC 174,500$101,0000.02%
Virtu KCG Holdings LLC 224,050$130,0000.00%
LMR Partners LLP 58,023$33,0000.00%
Tower Research Capital LLC (TRC) 35,078$20,0000.00%
Renaissance Technologies 2,221,086$1,290,0000.00%
EQUITEC SPECIALISTS, LLC 22,500$13,0000.00%
View complete list of GALENA BIOPHARMA INC shareholders